Skip to content

Clinical trials

Phase 3 Leukemia, Myeloid, Acute trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Phase: Phase 3 Country / region: Sweden Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20111
20151
20173
20182
20193
20211
20222
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting5
Recruiting5
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Stichting Hemato-Oncologie voor Volwassenen Nederland5
AbbVie2
Astex Pharmaceuticals, Inc.2
Cyclacel Pharmaceuticals, Inc.1
Daiichi Sankyo1
European Organisation for Research and Treatment of Cancer - EORTC1
Gilead Sciences1
Kiadis Pharma1
Novartis Pharmaceuticals1
PedAL BCU, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute19
Leukemia3
Neoplasms3
Precursor Cell Lymphoblastic Leukemia-Lymphoma3
Leukemia, Lymphocytic, Chronic, B-Cell2
Lymphoma, Non-Hodgkin2
Multiple Myeloma2
Blast Crisis1
Breast Neoplasms1
Burkitt Lymphoma1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.